Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease ("CVD") and overall health, announced today the publication of results of a prospective randomized ...
Paris (ots/PRNewswire) - The approval of Mifegyne(R) was the successful outcome of a long struggle. Its launch in France in 1989, soon followed by other European countries, was the final point of several decades of harsh debate, giving women more autonomy and the choice to medically terminate an unwanted pregnancy. Mifegyne(R) has changed the way abortion was perceived ...
Ballerup, Denmark (ots/PRNewswire) - Not for US media The digital press release with multimedia content can be accessed here: http://www.multivu.com/players/uk/7276254-WCCS-Picato-actinickeratosis New data from the international FIELD Study Repeat presented today at the 15th World Congress of Cancers of the Skin ...
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease ("CVD") and overall health, announced today that the cardio-protective effects of Pivotal's unique ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK based media - Detailed 26-week results of SPARK study presented at SSIEM Annual Symposium - Phenylalanine tolerance significantly increased in children with PKU below 4 years of age, previously shown to be responsive to Kuvan and treated with Kuvan plus a ...
Barcelona, Spain (ots/PRNewswire) - Registry provides new insights into AF treatment decisions, including patients' quality of life and treatment satisfaction[1],[2] (Photo: http://photos.prnewswire.com/prnh/20140902/703596 ) ESC Congress 2014, 02 September 2014, Barcelona, Spain: Daiichi Sankyo today announced one ...
Barcelona, Spain (ots/PRNewswire) - Registry provides new insights into AF treatment decisions, including patients' quality of life and treatment satisfaction[1],[2] (Photo: http://photos.prnewswire.com/prnh/20140902/703596 ) ESC Congress 2014, 02 September 2014, Barcelona, Spain: Daiichi Sankyo today announced one ...
Nantong, China (ots/PRNewswire) - - Merck Serono is the first and only multinational company in China to dedicate a large scale green-field investment to the production of pharmaceuticals on China's essential drug list - First shipment of drugs to patients in 2017 - Facility is designed to comply with the highest ...
Taking a Peek Behind Closed Doors! ColdChainIQ.com [http://www.coldchainiq.com/supply-chain-security/white-papers/cold-chain-iq-benchmarking-report-7-best-practice ] , a division of IQPC, is delighted to announce their brand new Benchmarking Report - a collection of some of the best case studies of leading pharmaceutical and biotech companies in the world. This report ...
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease ("CVD") and overall health, announced today that an article entitled, "Redox-sensitive induction of Src/PI3-kinase/Akt and MAPKs pathways activate eNOS in ...
Hatfield, England (ots/PRNewswire) - FOR EU MEDIA ONLY: NOT FOR SWISS MEDIA Accelerated Review Demonstrates the Importance of Lenvatinib for This Therapeutic Area The European Medicines Agency (EMA) has approved Eisai's request for accelerated assessment of the investigational oral multiple receptor tyrosine kinase ...
Darmstadt, Germany (ots/PRNewswire) - - First patient begins treatment in an international Phase II study investigating the efficacy and safety of MSB0010718C in patients with metastatic Merkel cell carcinoma (mMCC) - mMCC is a rare and aggressive skin cancer lacking effective treatments - MSB0010718C is also ...
Calgary, Alberta (ots/PRNewswire) - In addition, preliminary results from an Australian sponsored trial have yet to verify whether the mechanism of RVX-208 action may affect glucose metabolism. Resverlogix Corp. announced today findings from the recent analysis of Major Adverse Cardiovascular Events (MACE) data in ...
Amsterdam (ots/PRNewswire) - New panel additions Patheon, Almac and Arevepharma to provide global insights from the contract services sector CPhI expert panel members for 2014: 1) Prabir Basu, President at Pharma Manufacturing 2) Girish Malhotra, President & Founder, Epcot International [http://www.pharmaevolution.com/bloggers.asp#Girish_Malhotra ] 3) Hedley Rees, ...
London (ots/PRNewswire) - The Protection & Management Series 2014, organised by UBM Live, is pleased to announce its huge success following the first year at ExCeL London. Taking place from 17th-19th June, more than 40,000 attendees flooded through the doors to the series of events, the first time this milestone has been reached. (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a ) The Protection & Management ...
London (ots/PRNewswire) - A new report on tuberculosis (TB) published today by The Economist Intelligence Unit (EIU) investigates the increasing health challenges posed by TB and calls for new ways to improve the effectiveness of the global response to this pandemic.[1] The report supported by Janssen and titled ...
Bristol-Myers Squibb GmbH & Co. KGaA
Paris (ots/PRNewswire) - - The SHE network continues to expand across Europe to empower and educate women living with HIV and their health care providers - More than 60 SHE units, multidisciplinary teams based in HIV clinics and dedicated to women with HIV, have been implemented in 18 countries 'SHE' (Strong, HIV ...
Shire Pharmaceuticals Group Plc
Dublin (ots/PRNewswire) - Shire plc ("Shire" or the "Company") announces that its Canadian subsidiary(1) has received assessments from the Canadian revenue authorities, entitling it to total cash refunds equivalent to US$410 million(2). Following receipt of the assessments(3), the Company has recorded a net credit ...
Istanbul (ots/PRNewswire) - Successful first edition facilitates international partnerships and continued domestic manufacturing growth Leading events organiser, UBM Live, announces the successful launch of CPhI Istanbul 2014 [http://www.cphi-istanbul.com ], which took place on June 4th-6th 2014 at the Lutfi Kirdar International Convention and Exhibition Centre in ...
Shire Pharmaceuticals Group Plc
Dublin, Ireland (ots/PRNewswire) - NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. Shire plc ("Shire" or the "Company") notes today's announcement by AbbVie Inc. ("AbbVie") repeating its proposal of May 30, 2014, which comprised GBP20.44 in cash and 0.7988 AbbVie shares per Shire ...
Beerse, Belgium (ots/PRNewswire) - New report calls on governments to play their part and improve surveillance, screening and diagnosis of hepatitis C worldwide 'Tackling hepatitis C: Moving towards an integrated policy approach', a report published by The Economist Intelligence Unit (EIU) today reveals that many ...
Titusville, New Jersey (ots/PRNewswire) - Janssen Pharmaceuticals, Inc. (Janssen) announced today that it has entered into an exclusive license agreement with Vertex Pharmaceuticals for the worldwide development, manufacturing and commercialization of VX-787, a novel medicine in Phase II development for the treatment of influenza A. VX-787 is an investigational ...
Paris (ots/PRNewswire) - - Findings set foundation to drive recommendations for enhancing care - Sanofi announced today the first results of the TEENs Registry Study, the largest contemporary real-world study of the care of nearly 6,000 young people with type 1 diabetes, ages 8 to 25. The findings not only ...
Amsterdam (ots/PRNewswire) - - China's most important gathering of food and beverage industry professionals China's leading nutritional ingredients event, Food ingredients (Fi) Asia China, Health ingredients (Hi) and Natural ingredients (Ni), will take place this month, June 26-28 2014 in Shanghai, China. This is the premier event in China offering food & beverage ...
Paris (ots/PRNewswire) - Sanofi announced today that Lyxumia(R) (lixisenatide) met the primary endpoint in an 8-week head-to-head pharmacodynamic study versus liraglutide, showing a significantly more pronounced post-prandial (after-meal) glucose (blood sugar) lowering effect after a test-meal than liraglutide when ...
Paris (ots/PRNewswire) - - In EDITION JP I and II, investigational Toujeo(R)demonstrated similar blood sugar control with fewer night-time low blood sugar events over 6-month study period, vs. Lantus(R)- Sanofi announced today full results from EDITION JP I and EDITION JP II that showed Toujeo(R) (insulin glargine ...
Cork, Ireland (ots/PRNewswire) - Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT(R)) and ViiV's ...
Paris, France (ots/PRNewswire) - - New results for Toujeo(R)(insulin glargine [rDNA origin] injection, 300 U/mL; "U300") from EDITION I/II/III meta-analysis, EDITION III, IV, JP 1 and JP 2 studies are among over 65 abstracts to be presented - Sanofi announced today that new data on U300, Lyxumia(R) (lixisenatide) ...
Darmstadt, Germany (ots/PRNewswire) - - FDA clearance validates Eeva System, which enables in-vitro fertilization (IVF) clinicians to offer the proprietary Eeva Test and further demonstrates commitment by Merck Serono and Auxogyn to bring innovative technologies to the IVF community - Eeva Test first-of-a-kind ...
Hørsholm, Denmark (ots/PRNewswire) - First sublingual allergy immunotherapy tablet with robust results in allergic rhinitis and allergic asthma. Data supports European regulatory filing in 2H 2014 Today, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) has presented key trial results on its new sublingual allergy ...